DOI QR코드

DOI QR Code

Clinical Efficacy and Safety of Gyebutang Granules Combined with Acupuncture for the Treatment of Knee Osteoarthritis: Protocol for a Multicenter, Randomized, Assessor-blinded, 2-armed Parallel, Controlled Trial

  • Lee, Cham-Kyul (Department of Acupuncture & Moxibustion, Semyung University Korean Medicine Hospital) ;
  • Kang, Ha-Ra (Department of Korean Medicine, Dongguk University Graduate School) ;
  • Lee, Yeon-Sun (Department of Acupuncture & Moxibustion, Dongguk University Ilsan Oriental Hospital) ;
  • Sung, Won-Suk (Department of Acupuncture & Moxibustion, Dongguk University Bundang Oriental Hospital) ;
  • Lim, Chi-Yeon (Department of Biostatistics, School of Medicine, Dongguk University) ;
  • Jung, Chan-Yung (Department of Acupuncture & Moxibustion, Dongguk University Ilsan Oriental Hospital) ;
  • Kim, Eun-Jung (Department of Acupuncture & Moxibustion, Dongguk University Bundang Oriental Hospital) ;
  • Seo, Byung-Kwan (Department of Acupuncture & Moxibustion, College of Korean Medicine, Kyung Hee University) ;
  • Baek, Yong-Hyeon (Department of Acupuncture & Moxibustion, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Kyung-Ho (Department of Acupuncture & Moxibustion, Dongguk University Ilsan Oriental Hospital) ;
  • Lee, Eun-Young (Department of Acupuncture & Moxibustion, Semyung University Korean Medicine Hospital)
  • 투고 : 2020.01.21
  • 심사 : 2020.04.28
  • 발행 : 2020.05.31

초록

Background: Due to the aging population in Korea, knee osteoarthritis (KOA) has become an increasingly common condition. Many patients with KOA prefer analgesics, herbal medicines, acupuncture, or exercise, rather than arthroscopic surgery or a knee replacement. Gyebutang (GB) granules are a herbal extract widely used to treat KOA in traditional Korean medicine, but there is insufficient evidence of its efficacy and safety. Methods: A multicenter, randomized, assessor-blinded, 2-armed parallel, controlled clinical trial has been designed to investigate the efficacy and safety of GB combined with acupuncture for the treatment of KOA. There will be 100 patients with KOA enrolled in the study from 3 traditional Korean medicine hospitals. The participants will be randomly allocated to an experimental group (GB and acupuncture) or a control group (celecoxib and acupuncture) in a 1:1 ratio. Both groups will receive acupuncture treatment once a week for 6 weeks; one group will receive GB and the other will receive celecoxib for the same duration. Results: The primary outcome will be the change of knee osteoarthritic pain, based on scores on a 100 mm visual analog scale. The secondary outcomes will be scores on a numeric rating scale, the Western Ontario and McMaster Universities osteoarthritis index, patient global assessment, European quality of life 5-dimension 5-level scale, and adverse events. Conclusion: The results of this study will provide evidence of efficacy and safety of GB as a treatment for patients with KOA.

키워드

참고문헌

  1. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM et al. Osteoarthritis: new insights. Part 1: The disease and its risk factors. Ann Intern Med 2000;133:635-646. https://doi.org/10.7326/0003-4819-133-8-200010170-00016
  2. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: A review of community burden and current use of primary health care. Ann Rheum Dis 2001;60:91-97. https://doi.org/10.1136/ard.60.2.91
  3. Gerber LM, Chiu YL, Verjee M, Ghomrawi H. Health-related quality of life in midlife women in Qatar: Relation to arthritis and symptoms of joint pain. Menopause 2016;23:324-329. https://doi.org/10.1097/gme.0000000000000532
  4. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P et al. EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-1155. https://doi.org/10.1136/ard.2003.011742
  5. Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: Asystematic review. Osteoarthritis Cartilage 2011;19:1270-1285. https://doi.org/10.1016/j.joca.2011.08.009
  6. Fernandes L, Hagen KB, Bijlsma JW, Andreassen O, Christensen P, Conaghan PG et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 2013;72:1125-1135. https://doi.org/10.1136/annrheumdis-2012-202745
  7. Health Insurance Review andAssessment Service: Healthcare Bigdata Hub [Internet]. Medical Information Statistics. 2017. Available from: http:// opendata.hira.or.kr/op/opc/olapHifrqSickInfo.do.
  8. Quandt SA, Chen H, Grzywacz JG, Bell RA, Lang W, Arcury TA. Use of complementary and alternative medicine by persons with arthritis: Results of the National Health Interview Survey. Arthritis Rheum 2005;53:748-755. https://doi.org/10.1002/art.21443
  9. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994;309:107- 111. https://doi.org/10.1136/bmj.309.6947.107
  10. Lee SI, Khang YH, Lee MS, Koo HJ, Kang WC, Hong CG. Complementary and alternative medicine use in Korea: Prevalence, pattern of use, and outof- pocket expenditures. Korean J Prev Med 1999;32:546-555. [in Korean].
  11. Kim JI, Kang HS. Self-management of pain by folk remedies in patient with chronic arthritis. J Rheumatol Health 1999;6:242-252.
  12. Chandola A, Young Y, McAlister H, Axford JS. Use of complementary therapies by patients attending musculoskeletal clinics. J R Soc Med 1999;92:13-16.
  13. Boisset M, Fitzcharles MA. Alternative medicine use by rheumatology patients in a universal health care setting. J Rheumatol 1994;21:148-152.
  14. Vecchio PC. Attitudes to alternative medicine by rheumatology outpatient attenders. J Rheumatol 1994;21:145-147.
  15. Kim YR, Yoo TS, Park HK, Kim TH, Jun JB, Jung SS et al. Complementary and alternative medicine use and its usefulness in patients with RA. J Korean Rheum Assoc 2002;9:173-183. [in Korean].
  16. Jung HC, Park HM, Lee SD. Nationwide study on the characteristics of patients visiting and using Korean medical facilities by sex. J Korean Med 2014;35:75-87. [in Korean]. https://doi.org/10.13048/jkm.14008
  17. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol 2020;72:220-233. https://doi.org/10.1002/art.41142
  18. Witt C, Brinkhaus B, Jena S, Linde K, Streng A, Wagenpfeil S et al. Acupuncture in patients with osteoarthritis of the knee: Arandomised trial. Lancet 2005;366:136-143. https://doi.org/10.1016/S0140-6736(05)66871-7
  19. Scharf HP, Mansmann U, Streitberger K, Witte S, Kramer J, Maier C et al. Acupuncture and knee osteoarthritis: Athree-armed randomized trial. Ann Intern Med 2006;145:12-20. https://doi.org/10.7326/0003-4819-145-1-200607040-00005
  20. Cao L, Zhang XL, Gao YS, Jiang Y. Needle acupuncture for osteoarthritis of the knee. A systematic review and updated meta-analysis. Saudi Med J 2012;33:526-532.
  21. Chen N, Wang J, Mucelli A, Zhang X, Wang C. Electro-Acupuncture is Beneficial for Knee Osteoarthritis: The Evidence from Meta-Analysis of Randomized Controlled Trials.Am J Chin Med 2017;45:965-985. https://doi.org/10.1142/S0192415X17500513
  22. Jia J, Mao GI, Hu SH, Dong XC. Acupuncture combined with functional exercise for the elder patients with knee osteoarthritis. Chin J Tissue Eng Res 2005;9:18-19.
  23. Chang SH, Song YK, Nah SS. The clinical efficacy and safety of Gumiganghwal-tang in knee osteoarthritis: Aphase II randomized double blind placebo controlled study. Evid Based Complement Alternat Med 2018;2018:3165125.
  24. Srivastava S, Saksena AK, Khattri S, Kumar S, Dagur RS. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: Afour-month, double-blind, randomized, placebocontrolled trial. Inflammopharmacology 2016;24:377-388. https://doi.org/10.1007/s10787-016-0289-9
  25. Zakeri Z, Izadi S, Bari Z, Soltani F, Narouie B, Ghasemi-Rad M. Evaluating the effects of ginger extract on knee pain, stiffness, and difficulty in patients with knee osteoarthritis. J Med Plant Res 2011;5:3375-3379.
  26. Lee JH. Essential Formulae in Oriental Medicine with Illustrations, 1st revision ed. Wonju (Korea): Uibang Publications; 2007. 97 p.
  27. Ahn BS, Kim SK, Kim HN, Lee JH, Lee JH, Hwang DS et al. Gyejigachulbu-Tang relieves oxaliplatin-induced neuropathic cold and mechanical hypersensitivity in rats via the suppression of spinal glial activation. Evid Based Complement Alternat Med 2014;2014:436482.
  28. Schroder S, Beckmann K, Franconi G, Meyer-Hamme G, Friedemann T, Greten HJ et al. Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy? Evid Based Complement Alternat Med 2013;2013:423713.
  29. Jung Y, Lee JH, Kim W, Yoon SH, Kim SK. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression. BMC Complement Altern Med 2017;17:48. https://doi.org/10.1186/s12906-017-1556-z
  30. Nakanishi M, Arimitsu J, Kageyama M, Otsuka S, Inoue T, Nishida S et al. Efficacy of traditional Japanese herbal medicines - Keishikajutsubuto (TJ-18) and Bushi-matsu (TJ-3022) - against postherpetic neuralgia aggravated by self-reported cold stimulation: Acase series. J Altern Complement Med 2012;18:686-692. https://doi.org/10.1089/acm.2010.0745
  31. Satoh K, Takano S, Kobayashi T. Keishikajutsubuto (Guizhi-shu-fu-tang) treatment for refractory accumulation of synovial fluid in a patient with pustulotic arthro-osteitis. Fukushima J Med Sci 2007;53:33-38. https://doi.org/10.5387/fms.53.33
  32. Sul JU, Kim MK, Leem J, Jo HG, Yoon SH, Kim J et al. Efficacy and safety of gyejigachulbutang (Gui-Zhi-Jia-Shu-Fu-Tang, Keishikajutsubuto, TJ-18) for knee pain in patients with degenerative knee osteoarthritis: Arandomized, placebo-controlled, patient and assessor blinded clinical trial. Trials 2019;20:140. https://doi.org/10.1186/s13063-019-3234-6
  33. American college of rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-1915. https://doi.org/10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P
  34. Berman BM, Lao L, Langenberg P, Lee WL, Gilpin AM, Hochberg MC. Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: Arandomized, controlled trial. Ann Intern Med 2004;141:901-910. https://doi.org/10.7326/0003-4819-141-12-200412210-00006
  35. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983;16:87-101. https://doi.org/10.1016/0304-3959(83)90088-X
  36. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-158. https://doi.org/10.1016/S0304-3959(01)00349-9
  37. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: Ahealth status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-1840.
  38. Bae SC, Lee HS, Yun HR, Kim TH, Yoo DH, Kim SY. Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities (WOMAC) and Lequesne osteoarthritis indices for clinical research. Osteoarthritis Cartilage 2001;9:746-750. https://doi.org/10.1053/joca.2001.0471
  39. Rothman M, Vallow S, Damaraju CV, Hewitt DJ. Using the patient global assessment of the method of pain control to assess new analgesic modalities in clinical trials. Curr Med Res Opin 2009;25:1433-1443. https://doi.org/10.1185/03007990902862032
  40. Devlin NJ, Krabbe PF. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ 2013;14(Suppl 1):1-3. https://doi.org/10.1007/s10198-013-0502-3
  41. Kwon OS, Kim JE, Lee JW, Seo CW, Han HY, Hong SH. Analytic study of diagnostic validity by the measure of cold-heat anddeficiency-excess for oriental medical examination. J Physiol Pathol Korean Med 2009;23:180-185. [in Korean].
  42. Park YG, Ha CW, Han CD, Bin SI, Kim HC, Jung YB et al. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint. J Ethnopharmacol 2013;149:816-824. https://doi.org/10.1016/j.jep.2013.08.008
  43. Yoh SB, Sul JU, Shin MS. Research trends on the treatment of knee osteoarthritis in Korean Medicine. Korean J Acupunct 2011;28:139-155. [in Korean].
  44. Kimura M, Kimura I, Muroi M, Yoshizaki M, Hikino H. Pharmacological evidence for an interaction between constituents (blend effect) of the Japanese-Sino medicine "Keishi-ka-zyutubu-t?" in neuromuscular blockade in diabetic mice. Phytother Res 1987;1:107-113. https://doi.org/10.1002/ptr.2650010303
  45. Yamada T, Kan H, Matsumoto S, Koizumi M, Sasaki J, Tani A et al. Reduction in oxaliplatin-related neurotoxicity by the administration of Keishikajutsubuto (TJ-18) and powdered processed aconite root. Gan To Kagaku Ryoho 2012;39:1687-1691. [in Japanese].
  46. Shibata K, Sugawara T, Fujishita K, Shinozaki Y, Matsukawa T, Suzuki T et al. The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice. PLoS One 2011;6:e23510. https://doi.org/10.1371/journal.pone.0023510
  47. Kim YW, Zhao RJ, Park SJ, Lee JR, Cho IJ, Yang CH et al. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaBdependent iNOS and proinflammatory cytokines production. Br J Pharmacol 2008;154:165-173. https://doi.org/10.1038/bjp.2008.79
  48. Atsumi T, Iwashita A, Ohtsuka I, Kakiuchi N, Sasaki Y, Mikage M et al. Effects of Atractylodis Lanceae Rhizoma on inflammatory mediator production from the RAW264 macrophage cell line. J Trad Med 2013;30:124-131.
  49. Bose S, Kim H. Evaluation of in vitro anti-inflammatory activities and protective effect of fermented preparations of Rhizoma Atractylodis Macrocephalae on intestinal barrier function against lipopolysaccharide insult. Evid Based Complement Alternat Med 2013;2013:363076.
  50. Lee KO, Kuk YB, Yun YG. Effects of Jakyakgamchotang extract on the analgesic effect in mice. Herb Formula Sci 2003;11:161-170.
  51. Shin YS, Lee SI. A review study of researches on Jakyakgamcho-tang. Herb Formula Sci 2017;25:271-302. https://doi.org/10.14374/HFS.2017.25.2.271
  52. Myung NY. The improving effect of Zizyphus Jujube on dextran sulfate sodium-induced colitis in mice. Korea J Herbology 2015;30:35-40. [in Korean]. https://doi.org/10.6116/kjh.2015.30.3.35.
  53. Toriizuka M. The pharmacological action of kampo herbal prescription - Keishi-ka-jutsubu-to. Kampo Med 1997;21:184-189.
  54. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967;20:637-648. https://doi.org/10.1016/0021-9681(67)90041-0
  55. Macpherson H. Pragmatic clinical trials. Complement Ther Med 2004;12:136-140. https://doi.org/10.1016/j.ctim.2004.07.043
  56. Xu C, Gu K, Yasen Y, Hou Y. Efficacy and safety of Celecoxib therapy in osteoarthritis: Ameta-analysis of randomized controlled trials. Medicine (Baltimore) 2016;95:e3585. https://doi.org/10.1097/md.0000000000003585
  57. Song YJ, Ha CW. The use of COX-2 selective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis. J Korean Knee Soc 2009;21:84-92. [in Korean].